• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atreca, Inc. - Class A Common Stock (NQ:BCEL)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Atreca, Inc. - Class A Common Stock

News headline image
BCEL Stock Alert: Halper Sadeh LLC Is Investigating Atreca, Inc.
December 26, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome
December 26, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives
November 14, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
September 21, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
August 10, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
June 05, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
May 10, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
April 26, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 13, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
March 29, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
March 23, 2023
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of ATRC-101 
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
March 01, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
February 06, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
January 09, 2023
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
November 10, 2022
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca to Present at Upcoming Investor Conferences
November 07, 2022
From Atreca, Inc.
Via GlobeNewswire
News headline image
Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 05, 2022
From Atreca, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap